Anna Kron
Kerpener Str. 62
Koeln, NW 50931, Germany
Koeln, NW 50931, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 12, 2026
Concept and feasibility of privacy-preserving record linkage of cancer registry data and claims data in Germany: results from the DigiNet study on stage IV non-small cell lung cancer.
Journal: Journal of cancer research and clinical oncology
Published: September 11, 2025
Implementation of patient-reported outcomes in personalized lung cancer care: a qualitative study from the perspective of patients and health care providers.
Journal: Journal of patient-reported outcomes
Published: September 05, 2025
Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 17, 2025
Uncovering gaps in personalised lung cancer care in Germany: a white spot analysis.
Journal: BMC cancer
Published: July 06, 2025
Genetic prediction, molecular testing and complex treatment of lung cancer
Journal: MMW Fortschritte der Medizin
Published: June 04, 2025
DigiNet: Optimizing personalized care for patients with stage IV non-small cell lung cancer (NSCLC) through a digitally connected provider network-analysis plan of a prospective multicenter cohort trial.
Journal: Journal of cancer research and clinical oncology
Published: June 04, 2025
Evaluating docetaxel effectiveness in KRAS G12C-mutated NSCLC: insights from a Real-World cohort.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 22, 2025
Treatment Sequences in BRAF-V600-Mutated NSCLC: First-Line Targeted Therapy Versus First-Line (Chemo-) Immunotherapy.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 12, 2024
Corrigendum to "Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations" [Eur J Cancer 207 (2024) 114158].
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 30, 2024
Response to letter entitled: Re: Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 18, 2024
Last Updated: 09/26/2026